You are here

National Institutes of Health (NIH)

Tick bites likely lead to the unusual, misdiagnosed allergy.

Population study finds higher risk of psychiatric hospitalization among daughters of female evacuees.

NIH-supported study provides evidence for implementing approach broadly.

Study to test efficacy, safety of injectable cabotegravir compared with daily oral PrEP.

Public-private partnership begins clinical trial in sub-Saharan Africa.

Over 90 percent of homes had three or more detectable allergens.

After 30 years of marking progress against HIV, we are closer than ever to the beginning of the end of the HIV/AIDS pandemic.

Vaccine developed by NIH scientists shows promise in Phase 1 testing.